Professor of experimental cancer medicine (KCL) and consultant in medical oncology
James Spicer is professor of experimental cancer medicine, King’s College London, and consultant in medical oncology, Guy’s and St Thomas’ Hospital NHS Foundation Trust.
He runs the King’s Health Partners cancer phase 1 trials programme and leads the King’s Experimental Cancer Medicine Centre, funded by Cancer Research UK/National Institute for Health Research.
James' interests include the development of new cancer drugs, and the care of patients with thoracic malignancies, including lung cancer and mesothelioma. His
translational research focus is on novel immunotherapies.
Education and training
- FCRP (London), 2012
- PhD (ICR, University of London), 2002
- MRCP (London), 1998
- MB, BS (Guy’s and St Thomas’, University of London), 1995
- BA Biochemistry (Christ Church, University of Oxford), 1987
- 2004 - McElwain Prize from the Association of Cancer Physicians
- 1998 - Clinical Research Fellowship, Institute of Cancer Research
Clinical interests include the care of patients with thoracic malignancies, including lung cancer and mesothelioma, clinical trials in these diseases, and Phase 1 trials in all solid tumours.
Last updated: April 2022